ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,199Medicare Part D Prescriptions Filled, Including Refills

Rank: 65 out of 917

$683K Total Retail Price of All Prescriptions

Rank: 44 out of 917

346 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

14% of this provider’s 346 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 10,145 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
OMEPRAZOLE 840 774 1 4
AMLODIPINE BESYLATE 567 526 2 5
LOVASTATIN 445 373 3 19
ALENDRONATE SODIUM 392 384 4 23
LIDODERM 356 335 5 64
LOSARTAN POTASSIUM 330 291 6 13
LISINOPRIL 316 289 7 1
METFORMIN HCL 296 241 8 8
SIMVASTATIN 247 221 9 2
ATENOLOL 242 198 10 12
RANITIDINE HCL 236 190 11 29
FUROSEMIDE 217 199 12 7
METOPROLOL TARTRATE 201 181 13 11
CALCITRIOL 201 200 13 213
MELOXICAM 197 181 15 53
LEVOTHYROXINE SODIUM 172 153 16 3
TRAMADOL HCL 170 147 17 28
GLIPIZIDE ER 170 148 17 128
TRIAMTERENE-HCTZ 156 139 19 36
PAROXETINE HCL 143 142 20 57
LOSARTAN-HYDROCHLOROTHIAZIDE 143 111 20 62
ETODOLAC 139 125 22 182
HYDROCODONE-ACETAMINOPHEN 133 120 S3 23 6
CIPROFLOXACIN HCL 123 107 24 72
CELEBREX 120 120 25 124
DOXAZOSIN MESYLATE 115 115 26 74
NEXIUM 100 100 27 60
FLUTICASONE PROPIONATE 93 80 28 26
TAMSULOSIN HCL 92 92 29 25
METOPROLOL SUCCINATE 91 77 30 18
CLOPIDOGREL 90 86 31 50
POTASSIUM CHLORIDE 89 82 32 16
JANUMET 87 74 33 202
DIOVAN 86 82 34 49
CLOTRIMAZOLE-BETAMETHASONE 83 80 35 161
CRESTOR 80 75 36 30
CREON 78 76 37 156
WARFARIN SODIUM 78 78 37 10
GLIPIZIDE XL 77 56 39 142
TRAZODONE HCL 76 70 40 22
AZITHROMYCIN 74 67 41 61
MEGESTROL ACETATE 70 69 R 42 196
BOOSTRIX 69 60 43 110
GLIPIZIDE 68 47 44 40
ADVAIR DISKUS 66 65 45 47
ALLOPURINOL 66 61 45 31
SPIRIVA 65 55 47 45
PROAIR HFA 62 56 48 35
CITALOPRAM HBR 60 45 49 15
ATORVASTATIN CALCIUM 60 60 49 14
ISOSORBIDE MONONITRATE ER 59 57 51 70
PLAVIX 58 57 52 84
ADACEL 58 56 52 131
PREDNISONE 58 43 52 34
AMITRIPTYLINE HCL 55 40 R 55 67
TRILIPIX 55 51 55 215
SINGULAIR 54 54 57 153
CLOBETASOL PROPIONATE 51 47 58 203
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 11, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.